_id
69148b7accc777a4e85d999e
Ticker
PDRX
Name
Pd-Rx Pharmaceutical
Exchange
PINK
Address
727 North Ann Arbor, Oklahoma City, OK, United States, 73127
Country
USA
Sector
Healthcare
Industry
Medical Distribution
Currency
USD
Website
https://www.pdrx.com
Description
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to track prescriptions filled at the point of care and print prescription labels for prescriptions that are filled onsite. Further, it provides primary care, urgent care, pain management, occupational and orthopedic medicine, bariatric, dental, and other physician dispensing services. The company serves the governmental, commercial, and point-of-care pharmaceutical industry. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is based in Oklahoma City, Oklahoma.
Last Close
2.9
Volume
-
Current Price
3.33
Change
0
Last Updated
2026-01-06T09:01:06.840Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
4973761
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2016-06-30
Revenue
21468000
Cost Of Revenue
13728000
Gross Profit
-
Operating Expenses
-
Operating Income
762000
Interest Expense
-
Pretax Income
798000
Net Income
508000
Eps
-
Dividends Per Share
-
Shares Outstanding
1715090
Income Tax Expense
290000
EBITDA
-
Operating Margin
3.5494689770821686
Total Other Income Expense Net
-
Cash
5255000
Short Term Investments
2750000
Receivables
-
Inventories
1235000
Total Current Assets
-
Property Plant Equipment
957000
Total Assets
13250000
Payables
1043000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2024000
Equity
11226000
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-
Cash From Operations
1863000
Capital Expenditures
90000
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
USD
PE
2.6852
PB
-
ROE
4.525209335471227
ROA
3.8339622641509434
FCF
1773000
Fcf Percent
0.08258803801006148
Piotroski FScore
4
Health Score
52
Deep Value Investing Score
8.5
Defensive Investing Score
5
Dividend Investing Score
3
Economic Moat Investing Score
7.3
Garp Investing Score
5
Growth Investing Score
3.5
Momentum Investing Score
4
Net Net Investing Score
5.5
Quality Investing Score
4.5
Value Investing Score
5.5
Quarters > 0 > quarter
2016-06-30
Quarters > 0 > income Statement > revenue
21468000
Quarters > 0 > income Statement > cost Of Revenue
13728000
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
762000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
798000
Quarters > 0 > income Statement > net Income
508000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
290000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
3.5494689770821686
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
5255000
Quarters > 0 > balance Sheet > short Term Investments
2750000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
1235000
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
957000
Quarters > 0 > balance Sheet > total Assets
13250000
Quarters > 0 > balance Sheet > payables
1043000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2024000
Quarters > 0 > balance Sheet > equity
11226000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
508000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
1863000
Quarters > 0 > cash Flow > capital Expenditures
90000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
4.525209335471227
Quarters > 0 > ratios > ROA
3.8339622641509434
Quarters > 0 > ratios > FCF
1773000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.08258803801006148
Quarters > 0 > health Score
52
Quarters > 1 > quarter
2015-06-30
Quarters > 1 > income Statement > revenue
19387000
Quarters > 1 > income Statement > cost Of Revenue
11523000
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
881000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
925000
Quarters > 1 > income Statement > net Income
541000
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
384000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
4.544282250992934
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6232000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
1574000
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
1042000
Quarters > 1 > balance Sheet > total Assets
11970000
Quarters > 1 > balance Sheet > payables
413000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1252000
Quarters > 1 > balance Sheet > equity
10718000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
541000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
198000
Quarters > 1 > cash Flow > capital Expenditures
144000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
5.0475835043851465
Quarters > 1 > ratios > ROA
4.519632414369257
Quarters > 1 > ratios > FCF
54000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.0027853716407902204
Quarters > 1 > health Score
44
Quarters > 2 > quarter
2014-06-30
Quarters > 2 > income Statement > revenue
29121000
Quarters > 2 > income Statement > cost Of Revenue
18752000
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
3091000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
3124000
Quarters > 2 > income Statement > net Income
1964000
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
1160000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
10.614333298993852
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
6159000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
1903000
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
1109000
Quarters > 2 > balance Sheet > total Assets
11502000
Quarters > 2 > balance Sheet > payables
543000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1324000
Quarters > 2 > balance Sheet > equity
10178000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1964000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
2308000
Quarters > 2 > cash Flow > capital Expenditures
217000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
19.296521910001964
Quarters > 2 > ratios > ROA
17.07529125369501
Quarters > 2 > ratios > FCF
2091000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.07180385288966724
Quarters > 2 > health Score
69
Quarters > 3 > quarter
1999-12-31
Quarters > 3 > income Statement > revenue
1596063
Quarters > 3 > income Statement > cost Of Revenue
1167987
Quarters > 3 > income Statement > gross Profit
428077
Quarters > 3 > income Statement > operating Expenses
1561248
Quarters > 3 > income Statement > operating Income
34815
Quarters > 3 > income Statement > interest Expense
8532
Quarters > 3 > income Statement > pretax Income
40682
Quarters > 3 > income Statement > net Income
25223
Quarters > 3 > income Statement > eps
0.01999920710434507
Quarters > 3 > income Statement > dividends Per Share
2690
Quarters > 3 > income Statement > shares Outstanding
1261200
Quarters > 3 > income Statement > income Tax Expense
15459
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
2.181304873303873
Quarters > 3 > income Statement > total Other Income Expense Net
5867
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
104552
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
624744
Quarters > 3 > balance Sheet > inventories
650732
Quarters > 3 > balance Sheet > total Current Assets
1391765
Quarters > 3 > balance Sheet > property Plant Equipment
970386
Quarters > 3 > balance Sheet > total Assets
2362151
Quarters > 3 > balance Sheet > payables
309627
Quarters > 3 > balance Sheet > short Term Debt
16914
Quarters > 3 > balance Sheet > long Term Debt
449926
Quarters > 3 > balance Sheet > total Liabilities
870939
Quarters > 3 > balance Sheet > equity
1456092
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
25223
Quarters > 3 > cash Flow > depreciation
29924
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
25020
Quarters > 3 > cash Flow > capital Expenditures
44119
Quarters > 3 > cash Flow > cash From Investing
-44119
Quarters > 3 > cash Flow > cash From Financing
-12872
Quarters > 3 > cash Flow > net Change In Cash
-31971
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.01999920710434507
Quarters > 3 > ratios > PB
2.8842930254407
Quarters > 3 > ratios > ROE
1.732239446408606
Quarters > 3 > ratios > ROA
1.0677979519514205
Quarters > 3 > ratios > FCF
-19099
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.011966319625227826
Quarters > 3 > health Score
49
Annuals > 0 > quarter
2024-06-30
Annuals > 0 > income Statement > revenue
18946373
Annuals > 0 > income Statement > cost Of Revenue
13322415
Annuals > 0 > income Statement > gross Profit
5623958
Annuals > 0 > income Statement > operating Expenses
6575976
Annuals > 0 > income Statement > operating Income
-952018
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-712301
Annuals > 0 > income Statement > net Income
-753495
Annuals > 0 > income Statement > eps
-0.45813912199653917
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1644686
Annuals > 0 > income Statement > income Tax Expense
41194
Annuals > 0 > income Statement > EBITDA
-560022
Annuals > 0 > income Statement > operating Margin
-5.0248034280756535
Annuals > 0 > income Statement > total Other Income Expense Net
239717
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
5403390
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
3178261
Annuals > 0 > balance Sheet > inventories
2232749
Annuals > 0 > balance Sheet > total Current Assets
11347698
Annuals > 0 > balance Sheet > property Plant Equipment
1436317
Annuals > 0 > balance Sheet > total Assets
12867698
Annuals > 0 > balance Sheet > payables
1518666
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2369411
Annuals > 0 > balance Sheet > equity
10498287
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-753495
Annuals > 0 > cash Flow > depreciation
152276
Annuals > 0 > cash Flow > change In Working Capital
-963073
Annuals > 0 > cash Flow > cash From Operations
-1350942
Annuals > 0 > cash Flow > capital Expenditures
77938
Annuals > 0 > cash Flow > cash From Investing
-77934
Annuals > 0 > cash Flow > cash From Financing
-1250
Annuals > 0 > cash Flow > net Change In Cash
-1430126
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.45813912199653917
Annuals > 0 > ratios > PB
0.4543207287055498
Annuals > 0 > ratios > ROE
-7.177313784620291
Annuals > 0 > ratios > ROA
-5.855709389511628
Annuals > 0 > ratios > FCF
-1428880
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.07541707323085005
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-06-30
Annuals > 1 > income Statement > revenue
21271614
Annuals > 1 > income Statement > cost Of Revenue
14558582
Annuals > 1 > income Statement > gross Profit
6713032
Annuals > 1 > income Statement > operating Expenses
6901506
Annuals > 1 > income Statement > operating Income
-190477
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-126776
Annuals > 1 > income Statement > net Income
-98064
Annuals > 1 > income Statement > eps
-0.06
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1634400
Annuals > 1 > income Statement > income Tax Expense
-28712
Annuals > 1 > income Statement > EBITDA
12281
Annuals > 1 > income Statement > operating Margin
-0.8954515628198217
Annuals > 1 > income Statement > total Other Income Expense Net
63701
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6833516
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2376980
Annuals > 1 > balance Sheet > inventories
1640375
Annuals > 1 > balance Sheet > total Current Assets
11392455
Annuals > 1 > balance Sheet > property Plant Equipment
1523884
Annuals > 1 > balance Sheet > total Assets
12950236
Annuals > 1 > balance Sheet > payables
992920
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1697204
Annuals > 1 > balance Sheet > equity
11253032
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-98064
Annuals > 1 > cash Flow > depreciation
139058
Annuals > 1 > cash Flow > change In Working Capital
1897591
Annuals > 1 > cash Flow > cash From Operations
1788703
Annuals > 1 > cash Flow > capital Expenditures
426842
Annuals > 1 > cash Flow > cash From Investing
-426842
Annuals > 1 > cash Flow > cash From Financing
-710
Annuals > 1 > cash Flow > net Change In Cash
1361151
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.06
Annuals > 1 > ratios > PB
0.4211984823290292
Annuals > 1 > ratios > ROE
-0.8714451358531639
Annuals > 1 > ratios > ROA
-0.7572371654076421
Annuals > 1 > ratios > FCF
1361861
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.06402245734620796
Annuals > 1 > health Score
39
Annuals > 2 > quarter
2022-06-30
Annuals > 2 > income Statement > revenue
28715224
Annuals > 2 > income Statement > cost Of Revenue
17652846
Annuals > 2 > income Statement > gross Profit
11062378
Annuals > 2 > income Statement > operating Expenses
7027070
Annuals > 2 > income Statement > operating Income
4004378
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
4052753
Annuals > 2 > income Statement > net Income
3033984
Annuals > 2 > income Statement > eps
1.830000832371281
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1657914
Annuals > 2 > income Statement > income Tax Expense
1018769
Annuals > 2 > income Statement > EBITDA
4131262
Annuals > 2 > income Statement > operating Margin
13.945139344899415
Annuals > 2 > income Statement > total Other Income Expense Net
48375
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5472365
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
4456252
Annuals > 2 > balance Sheet > inventories
1836563
Annuals > 2 > balance Sheet > total Current Assets
11984458
Annuals > 2 > balance Sheet > property Plant Equipment
1238103
Annuals > 2 > balance Sheet > total Assets
13222561
Annuals > 2 > balance Sheet > payables
1158667
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1860760
Annuals > 2 > balance Sheet > equity
11351806
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
3033984
Annuals > 2 > cash Flow > depreciation
126884
Annuals > 2 > cash Flow > change In Working Capital
8274
Annuals > 2 > cash Flow > cash From Operations
3235367
Annuals > 2 > cash Flow > capital Expenditures
550207
Annuals > 2 > cash Flow > cash From Investing
-502707
Annuals > 2 > cash Flow > cash From Financing
-165200
Annuals > 2 > cash Flow > net Change In Cash
2567460
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
1.830000832371281
Annuals > 2 > ratios > PB
0.4235405890481215
Annuals > 2 > ratios > ROE
26.72688381038224
Annuals > 2 > ratios > ROA
22.94550957261608
Annuals > 2 > ratios > FCF
2685160
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.09350997923610138
Annuals > 2 > health Score
83
Annuals > 3 > quarter
2021-06-30
Annuals > 3 > income Statement > revenue
21602200
Annuals > 3 > income Statement > cost Of Revenue
14645407
Annuals > 3 > income Statement > gross Profit
6956793
Annuals > 3 > income Statement > operating Expenses
6080322
Annuals > 3 > income Statement > operating Income
876470
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
1834692
Annuals > 3 > income Statement > net Income
1856324
Annuals > 3 > income Statement > eps
1.082350389426536
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1715086
Annuals > 3 > income Statement > income Tax Expense
-21632
Annuals > 3 > income Statement > EBITDA
1949324
Annuals > 3 > income Statement > operating Margin
4.057318236105582
Annuals > 3 > income Statement > total Other Income Expense Net
958222
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2904905
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3887611
Annuals > 3 > balance Sheet > inventories
2651956
Annuals > 3 > balance Sheet > total Current Assets
9998630
Annuals > 3 > balance Sheet > property Plant Equipment
831350
Annuals > 3 > balance Sheet > total Assets
10914396
Annuals > 3 > balance Sheet > payables
1646540
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2431374
Annuals > 3 > balance Sheet > equity
8483022
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
1856324
Annuals > 3 > cash Flow > depreciation
114633
Annuals > 3 > cash Flow > change In Working Capital
-1741791
Annuals > 3 > cash Flow > cash From Operations
-465775
Annuals > 3 > cash Flow > capital Expenditures
107925
Annuals > 3 > cash Flow > cash From Investing
-85925
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-551700
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.082350389426536
Annuals > 3 > ratios > PB
0.586318106919916
Annuals > 3 > ratios > ROE
21.882814874227606
Annuals > 3 > ratios > ROA
17.00803232721261
Annuals > 3 > ratios > FCF
-573700
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.026557480256640526
Annuals > 3 > health Score
73
Valuation > metrics > PE
2.6852
Valuation > final Score
70
Valuation > verdict
73.1% Undervalued
Profitability > metrics > ROE
4.525209335471227
Profitability > metrics > Net Margin
0.023663126513881125
Profitability > final Score
28
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1802957420274363
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
0
Liquidity > metrics > Quick Ratio
-1.184084372003835
Liquidity > final Score
-49
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
100
Prev Profitabilities > 0
29
Prev Profitabilities > 1
64
Prev Profitabilities > 2
11
Prev Risks > 0
80
Prev Risks > 1
80
Prev Risks > 2
64
Prev Liquidities > 0
-181
Prev Liquidities > 1
-165
Prev Liquidities > 2
100
Updated At
2026-01-20T22:22:56.808Z
Earnings History > 0 > period
1999-12-31
Earnings History > 0 > report Date
2000-03-01
Earnings History > 0 > date
1999-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.02
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0.02
Earnings History > 0 > surprise Percent
-
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to track prescriptions filled at the point of care and print prescription labels for prescriptions that are filled onsite. Further, it provides primary care, urgent care, pain management, occupational and orthopedic medicine, bariatric, dental, and other physician dispensing services. The company serves the governmental, commercial, and point-of-care pharmaceutical industry. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is based in Oklahoma City, Oklahoma.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2016-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Pd-Rx Pharmaceutical
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
1999-12-31
EPS Actual
0.02
EPS Estimate
0
EPS Difference
0.02
Surprise Percent
0%
(Last Updated 2016-06-30)
(Last Updated 2016-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2016-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2016-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.